← Leaderboards
Janet L Funk
University Of Arizona
$4,290,001
Attributed
$4,290,001
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $703.3K · FY2006–22$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,490,001 · 8
By mechanism
R21$1,805,932 · 4
R01$1,594,520 · 1
P50$1,200,000 · 1
R34$736,799 · 1
R03$152,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- Barbara Timmermann$8,132,672
- Zelieann Rivera Craig$5,375,100
- David E Nix$777,003
- Jennifer K. Barton$15,034,989
- Laura Elizabeth Wright$148,028
Others in their field
Top investigators on “Dietary Supplements”
- Anastassios G Pittas · Tufts Medical Center$49,695,816
- Ikhlas Ahmad Khan · University Of Mississippi$39,794,183
- Joann Elisabeth Manson · Brigham And Women'S Hospital$26,110,300
- John Anthony Baron · Dartmouth College$23,369,919
- Julie E Buring · Brigham And Women'S Hospital$21,370,238
- Charles Hebert · Southern Research Institute$20,298,000
Research focus
Dietary SupplementsPreventionTumericClinical TrialsPreventFutureInhibitor/AntagonistBoneArthritisIn VivoIn VitroWomanFundingDesignCurcuminSiteBone ResorptionResearch PersonnelSafetyBone DiseasesLaboratoriesProtective EffectBotanicalsDrug Kinetics
Grant awards (23)
Mechanistic Determinants of Dietary Polyphenol Bioactivity in Bone$170,471
R21 · FY2022 · AR · contact PI
Mechanistic Determinants of Dietary Polyphenol Bioactivity in Bone$212,103
R21 · FY2021 · AR · contact PI
Exploiting the Tumor Microenvironment to Block Breast Cancer Bone Metastasis$317,423
R01 · FY2018 · CA · contact PI
Exploiting the Tumor Microenvironment to Block Breast Cancer Bone Metastasis$317,423
R01 · FY2017 · CA · contact PI
Exploiting the Tumor Microenvironment to Block Breast Cancer Bone Metastasis$317,423
R01 · FY2016 · CA · contact PI
Exploiting the Tumor Microenvironment to Block Breast Cancer Bone Metastasis$318,748
R01 · FY2015 · CA · contact PI
Curcuma longa L. in Rheumatoid Arthritis (CLaRA): Clinical Planning Study$287,246
R34 · FY2015 · AT · contact PI
Isolation and Characterization of ER+ Breast Cancer Cells with High Bone Metastat$76,500
R03 · FY2015 · CA · contact PI
Exploiting the Tumor Microenvironment to Block Breast Cancer Bone Metastasis$323,503
R01 · FY2014 · CA · contact PI
Curcuma longa L. in Rheumatoid Arthritis (CLaRA): Clinical Planning Study$274,864
R34 · FY2014 · AT · contact PI
Isolation and Characterization of ER+ Breast Cancer Cells with High Bone Metastat$76,250
R03 · FY2014 · CA · contact PI
Curcuma longa L. in Rheumatoid Arthritis (CLaRA): Clinical Planning Study$28,701
R34 · FY2014 · AT · contact PI
Curcuma longa L. in Rheumatoid Arthritis (CLaRA): Clinical Planning Study$145,988
R34 · FY2013 · AT · contact PI
Identification of Natural Product Inhibitors of Breast Cancer Bone Metastasis$99,332
R21 · FY2012 · AT · contact PI
Identification of Natural Product Inhibitors of Breast Cancer Bone Metastasis$186,145
R21 · FY2011 · AT · contact PI
Identification of Natural Product Inhibitors of Breast Cancer Bone Metastasis$237,830
R21 · FY2010 · AT · contact PI
Anti-Arthritic Effects of Ginger Dietary Supplements$187,000
R21 · FY2009 · AT · contact PI
Efficacy of Turmeric Extract in Prevention of Post-menopausal Osteoporosis$10,322
R21 · FY2009 · AT · contact PI
Anti-Arthritic Effects of Ginger Dietary Supplements$236,000
R21 · FY2008 · AT · contact PI
Efficacy of Turmeric Extract in Prevention of Post-menopausal Osteoporosis$56,953
R21 · FY2008 · AT · contact PI
Efficacy of Turmeric Extract in Prevention of Post-menopausal Osteoporosis$183,276
R21 · FY2007 · AT · contact PI
Efficacy of Turmeric Extract in Prevention of Post-menopausal Osteoporosis$226,500
R21 · FY2006 · AT · contact PI
ARIZONA CENTER FOR PHYTOMEDICINE RESEARCH (ACPRX)$1,200,000
P50 · FY2004 · AT